留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

儿童肥胖并发脂肪肝的危险因素分析

赵康路 居红珍

赵康路, 居红珍. 儿童肥胖并发脂肪肝的危险因素分析[J]. 分子影像学杂志, 2018, 41(2): 257-260. doi: 10.3969/j.issn.1674-4500.2018.02.28
引用本文: 赵康路, 居红珍. 儿童肥胖并发脂肪肝的危险因素分析[J]. 分子影像学杂志, 2018, 41(2): 257-260. doi: 10.3969/j.issn.1674-4500.2018.02.28
KangLu ZHAO, HongZhen JU. Risk factors of fatty liver in obese children[J]. Journal of Molecular Imaging, 2018, 41(2): 257-260. doi: 10.3969/j.issn.1674-4500.2018.02.28
Citation: KangLu ZHAO, HongZhen JU. Risk factors of fatty liver in obese children[J]. Journal of Molecular Imaging, 2018, 41(2): 257-260. doi: 10.3969/j.issn.1674-4500.2018.02.28

儿童肥胖并发脂肪肝的危险因素分析

doi: 10.3969/j.issn.1674-4500.2018.02.28
详细信息
    作者简介:

    赵康路,医师,E-mail: 8016019@zju.edu.cn

Risk factors of fatty liver in obese children

  • 摘要: 目的 分析肥胖儿童并发脂肪肝的危险因素。 方法 搜集2014年1月~2016年12月在某三甲医院住院的肥胖儿童,并通过肝脏B超的检测,将肥胖儿童分成单纯肥胖组和肥胖合并脂肪肝组。计算体质量指数和体内平衡模型胰岛素抵抗指数(HOMA-IR)。 结果 共186例患者纳入研究,单纯肥胖组和肥胖合并脂肪肝组均为93例。肥胖合并脂肪肝组的男性比例、年龄、腰围、体质量指数水平比单纯肥胖组高,差异有统计学意义(P<0.05)。年龄、HOMA-IR和尿酸是肥胖儿童发生脂肪肝的危险因素(OR>1,P<0.05)。 结论 男性、大龄、HOMA-IR和尿酸高的肥胖儿童更容易出现脂肪肝。

     

  • 表  1  两组患者的一般情况和代谢特点比较(n=93)

    因素 单纯肥胖组 肥胖合并脂肪肝组 P
    性别[男,n(%)] 54(58%) 73(78%) 0.003
    年龄(岁) 9(1, 16) 12(7, 16) 0.000
    BMI(kg/m2 25.5±3.4 28.1±3.7 0.000
    腰围(cm) 83.5±11.5 92.0±9.9 0.000
    BMI: 体质量指数.
    下载: 导出CSV

    表  2  肥胖儿童脂肪肝危险因素分析

    因素 B S.E. Wald P OR 95%CI
    性别 0.525 0.391 1.803 0.179 1.691 0.786~3.640
    年龄 0.201 0.091 4.818 0.028 1.222 1.022~1.462
    BMI 0.065 0.087 0.568 0.451 1.067 0.901~1.265
    腰围 0.000 0.031 0.000 0.992 1.000 0.940~1.063
    HOMA-IR 0.105 0.054 3.811 0.050 1.111 1.000~1.234
    甘油三酯 0.165 0.385 0.183 0.668 1.179 0.554~2.510
    总胆固醇 -0.468 0.546 0.735 0.391 0.626 0.215~1.825
    HDL-C 1.191 0.793 2.258 0.133 3.290 0.696~15.554
    LDL-C 0.369 0.595 0.385 0.535 1.446 0.451~4.640
    尿酸 0.004 0.002 4.131 0.042 1.004 1.000~1.008
    BMI: 体质量指数; HOMA-IR: 体内平衡模型胰岛素抵抗指数; HDL-C: 高密度脂蛋白胆固醇; LDL-C: 低密度脂蛋白胆固醇.
    下载: 导出CSV
  • [1] Wang S, Dong YH, Wang ZH, et al. Trends in overweight and obesity among Chinese children of 7-18 years old during 1985-2014[J]. Chin J Prevent Med, 2017,51(4): 300-5.
    [2] Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J]. J Gastroenterol Hepatol, 2013, 28(1, SI): 11-7.
    [3] Meng L, Luo N, Mi J. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children[J]. Biomed Environment Scien, 2011, 24(1): 22-30.
    [4] 李华, 肖延风, 尹春燕, 等. 单纯性肥胖儿童脂肪肝相关危险因素分析[J]. 中国妇幼健康研究, 2017, 16(04): 366-8. doi: 10.3969/j.issn.1673-5293.2017.04.002
    [5] 冯海霞, 万燕萍, 周一泉, 等. 儿童单纯性肥胖相关危险因素的性别差异[J]. 中华实用儿科临床杂志, 2014, 29(19): 1471-5. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_syeklczz201419009
    [6] Cole TJ, Lobstein T. Body mass index cut-offs for thinness,overweight and obesity[J]. Pediatr Obes, 2012, 7(4): 284-94. doi: 10.1111/ijpo.2012.7.issue-4
    [7] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J]. Gastroenterology, 2012, 142(7): 1592-609. doi: 10.1053/j.gastro.2012.04.001
    [8] Xu C, Yu C, Ma H,et al. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population:the Zhejiang Zhenhai Study[J]. Am J Gastroenterol , 2013, 108(8): 1299-304. doi: 10.1038/ajg.2013.104
    [9] Alkassabany YM, Farghaly AG, El-Ghitany EM. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt[J]. Arab J Gastroenterol, 2014, 15(2): 76-81. doi: 10.1016/j.ajg.2014.05.002
    [10] Zhang HX, Xu XQ, Fu JF, et al. Predicting hepatic steatosis and liver fat content in obese children based on biochemical parameters and anthropometry[J]. Pediatr Obes, 2015, 10(2): 112-7. doi: 10.1111/ijpo.2015.10.issue-2
    [11] Awai HI, Newton KP, Sirlin CB,et al. Evidence and recommendations for imaging liver fat in children. Based on systematic review[J]. Clin Gastroenterol Hepatol, 2014, 12(5): 765-73. doi: 10.1016/j.cgh.2013.09.050
    [12] 刘燕妮, 张知新. 儿童非酒精性脂肪肝发病机制研究进展[J]. 中日友好医院学报, 2015,18(04): 257-9. doi: 10.3969/j.issn.1001-0025.2015.04.020
    [13] Rinella ME. Nonalcoholic fatty liver disease:a systematic review[J]. JAMA, 2015, 314(14): 2263-73.
    [14] Zhang H, Yang H, Lai C, et al. Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents[J]. Clin Endocrinol (Oxf), 2015, 83(1): 43-9. doi: 10.1111/cen.2015.83.issue-1
    [15] 胡伟, 尹春燕, 肖延风. 代谢异常在单纯性肥胖儿童脂肪肝中的作用[J]. 中国妇幼健康研究, 2015,16(02): 191-3. doi: 10.3969/j.issn.1673-5293.2015.02.008
    [16] 康如彤, 钟燕, 蒋耀辉, 等. 肥胖儿童非酒精性脂肪肝影响因素分析[J]. 实用预防医学, 2013, 20(03): 277-9. doi: 10.3969/j.issn.1006-3110.2013.03.007
    [17] Bonakdaran S, Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes[J]. Curr Diabetes Rev, 2014, 10(2): 113-7. doi: 10.2174/1573399810666140228160938
    [18] Choi YJ, Shin HS, Choi HS, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J]. Lab Invest, 2014, 94(10): 1114-25. doi: 10.1038/labinvest.2014.98
    [19] Chernyak OO, Sentsova TB, Vorozhko IV, et al. Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients[J]. Voprosy Pitan,2015, 84(4): 18-24.
    [20] Li M, Zhang S, Wu Y, et al. Prevalence of insulin resistance in subjects with nonalcoholic fatty liver disease and its predictors in a Chinese population[J]. Dig Dis Sci, 2015, 60(7): 2170-6. doi: 10.1007/s10620-015-3564-5
    [21] Dixon JB, Bhathal PS, O'brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese[J]. Gastroenterology, 2001, 121(1): 91-100. doi: 10.1053/gast.2001.25540
    [22] Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease[J]. Atherosclerosis, 2015, 239(1): 192-202. doi: 10.1016/j.atherosclerosis.2015.01.001
    [23] Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome[J]. Lancet Diab Endocrinol, 2014, 2(11): 901-10. doi: 10.1016/S2213-8587(14)70032-4
    [24] 刘瑞侠, 黄有烨, 胡红琳. 肥胖症非酒精性脂肪肝病的发病机制研究进展[J]. 安徽医学, 2017,32(04): 512-6. doi: 10.3969/j.issn.1000-0399.2017.04.038
    [25] Cai W, Song JM, Zhang B, et al. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population[J]. Scien World J, 2014,22(7): 393628-35.
  • 加载中
表(2)
计量
  • 文章访问数:  793
  • HTML全文浏览量:  286
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-01-30
  • 刊出日期:  2018-04-01

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日